A
$ Value
$0
Shares
11,420
Price
$0
Filed
Nov 17
Insider
Name
Glass Mitchell
Title
Director, Chief Medical Off.
CIK
0002023649
Roles
Director
Officer
Transaction Details
Transaction Date
2025-11-14
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
12,500
Footnotes
Represents a grant of Restricted Stock Units ("RSUs"). The RSUs were granted to the Reporting Person on October 3, 2025, subject to stockholder approval of an amendment to the Issuer's Q/C Technologies, Inc. 2021 Equity Incentive Plan (the "Plan Amendment"), under which the RSUs were granted. The Issuer's stockholders approved the Plan Amendment on November 14, 2025. The RSUs vested immediately upon issuance.
Filing Info
Glass Mitchell's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-13 | QCLS | A | $0 |
| 2025-11-14 | QCLS | A | $0 |
| 2025-10-03 | QCLS | A | $0 |
Other Insiders at QCLS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Silverman Joshua
Executive Chairman
|
— | — | 2026-04-13 |
| White Billy Joe | — | — | 2026-04-13 |
| Bernstein Bruce | — | — | 2026-04-13 |
|
Glass Mitchell
Chief Medical Officer
|
— | — | 2026-04-13 |
| Friscia Stephen | — | — | 2026-04-13 |
| Voss Chelsea Sierra | — | — | 2026-04-13 |